Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03652948 · ClinicalTrials.gov registry record · Phase 2
Meru Health Ascend Mobile Intervention for Depression in Middle Aged and Older Adults
A Phase 2 study, sponsored by Palo Alto Veterans Institute for Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT03652948 is a Phase 2 study that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 70 participants.
The verdict
NCT03652948, a Phase 2 study, has completed, sponsored by Palo Alto Veterans Institute for Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
Using technology to deliver depression interventions is one way could alleviate the public health burden of depression. The study is testing a mobile app intervention program for depression that uses cognitive behavioral skills and mindfulness. This study seeks to obtain feedback on the intervention and refine the intervention and then test the intervention in a larger study. The mobile app intervention called the Meru Health Ascend program consists of the app and therapist support via messaging within the app.
Interventions
- BEHAVIORAL Meru Health Ascend Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2021-01-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03652948
The ClinicalTrials.gov registry entry for NCT03652948 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto Veterans Institute for Research, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Meru Health Ascend Program is the first listed.
NCT03652948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03652948 about?
NCT03652948 is a clinical study titled "Meru Health Ascend Mobile Intervention for Depression in Middle Aged and Older Adults". Using technology to deliver depression interventions is one way could alleviate the public health burden of depression. The study is testing a mobile app intervention program for depression that uses cognitive behavioral skills and mindfulness. This study seeks to obtain feedback on the intervention...
What is the current status of trial NCT03652948?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2018-07-12. Estimated completion is 2021-01-15.
What interventions are being tested in trial NCT03652948?
The interventions under investigation include: Meru Health Ascend Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03652948?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.